Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-004161
Filing Date
2022-03-23
Accepted
2022-03-23 16:43:27
Documents
96
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K eqrx-20211231x10k.htm   iXBRL 10-K 3455955
2 EX-10.12 eqrx-20211231xex10d12.htm EX-10.12 127614
3 EX-23.1 eqrx-20211231xex23d1.htm EX-23.1 2512
4 EX-31.1 eqrx-20211231xex31d1.htm EX-31.1 18755
5 EX-31.2 eqrx-20211231xex31d2.htm EX-31.2 18133
6 EX-32 eqrx-20211231xex32.htm EX-32 14098
7 GRAPHIC eqrx-20211231x10k001.jpg GRAPHIC 39300
8 GRAPHIC eqrx-20211231x10k002.jpg GRAPHIC 48742
9 GRAPHIC eqrx-20211231x10k003.jpg GRAPHIC 51932
10 GRAPHIC eqrx-20211231x10k004.jpg GRAPHIC 45637
11 GRAPHIC eqrx-20211231x10k005.jpg GRAPHIC 113338
12 GRAPHIC eqrx-20211231x10k006.jpg GRAPHIC 70782
13 GRAPHIC eqrx-20211231x10k007.jpg GRAPHIC 74545
14 GRAPHIC eqrx-20211231x10k008.jpg GRAPHIC 66775
15 GRAPHIC eqrx-20211231x10k009.jpg GRAPHIC 54398
16 GRAPHIC eqrx-20211231x10k010.jpg GRAPHIC 68013
17 GRAPHIC eqrx-20211231xex10d12001.jpg GRAPHIC 3635
  Complete submission text file 0001558370-22-004161.txt   12626696

Data Files

Seq Description Document Type Size
18 EX-101.SCH eqrx-20211231.xsd EX-101.SCH 65126
19 EX-101.CAL eqrx-20211231_cal.xml EX-101.CAL 55072
20 EX-101.DEF eqrx-20211231_def.xml EX-101.DEF 283981
21 EX-101.LAB eqrx-20211231_lab.xml EX-101.LAB 600145
22 EX-101.PRE eqrx-20211231_pre.xml EX-101.PRE 495752
90 EXTRACTED XBRL INSTANCE DOCUMENT eqrx-20211231x10k_htm.xml XML 1618189
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 6173152266
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

EIN.: 861691173 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40312 | Film No.: 22763668
SIC: 2834 Pharmaceutical Preparations